A high CRP and low pentraxin 3 were linked to a high risk of thrombotic events in PV and in ET, and a high CRP was associated with shortened leukemia-free survival in MPN patients with myelofibrosis [64, 65]. This evidence concerns the gene CRP and acquired polycythemia vera.